DE60035522T2 - Mutant er-alpha und nachweissysteme für transaktivierung - Google Patents

Mutant er-alpha und nachweissysteme für transaktivierung Download PDF

Info

Publication number
DE60035522T2
DE60035522T2 DE60035522T DE60035522T DE60035522T2 DE 60035522 T2 DE60035522 T2 DE 60035522T2 DE 60035522 T DE60035522 T DE 60035522T DE 60035522 T DE60035522 T DE 60035522T DE 60035522 T2 DE60035522 T2 DE 60035522T2
Authority
DE
Germany
Prior art keywords
erα
seq
relative position
reporter gene
mutant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60035522T
Other languages
German (de)
English (en)
Other versions
DE60035522D1 (de
Inventor
Koichi Takarazuka-shi SAITO
Norihisa Nara-shi OHE
Hideo Ibaraki-shi SATOH
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Publication of DE60035522D1 publication Critical patent/DE60035522D1/de
Application granted granted Critical
Publication of DE60035522T2 publication Critical patent/DE60035522T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Mushroom Cultivation (AREA)
DE60035522T 1999-12-07 2000-12-01 Mutant er-alpha und nachweissysteme für transaktivierung Expired - Lifetime DE60035522T2 (de)

Applications Claiming Priority (17)

Application Number Priority Date Filing Date Title
JP34802299 1999-12-07
JP34802299 1999-12-07
JP37066799 1999-12-27
JP37066799 1999-12-27
JP2000207011 2000-07-07
JP2000207011 2000-07-07
JP2000220508 2000-07-21
JP2000220508 2000-07-21
JP2000234053 2000-08-02
JP2000234053 2000-08-02
JP2000235463 2000-08-03
JP2000235460 2000-08-03
JP2000235461 2000-08-03
JP2000235460 2000-08-03
JP2000235461 2000-08-03
JP2000235463 2000-08-03
PCT/JP2000/008553 WO2001042307A1 (en) 1999-12-07 2000-12-01 MUTANT ERα AND TEST SYSTEMS FOR TRANSACTIVATION

Publications (2)

Publication Number Publication Date
DE60035522D1 DE60035522D1 (de) 2007-08-23
DE60035522T2 true DE60035522T2 (de) 2008-03-20

Family

ID=27573667

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60035522T Expired - Lifetime DE60035522T2 (de) 1999-12-07 2000-12-01 Mutant er-alpha und nachweissysteme für transaktivierung

Country Status (8)

Country Link
US (1) US7582476B2 (enExample)
EP (1) EP1237925B1 (enExample)
JP (1) JP4742483B2 (enExample)
AT (1) ATE366745T1 (enExample)
AU (1) AU782142B2 (enExample)
CA (1) CA2393045A1 (enExample)
DE (1) DE60035522T2 (enExample)
WO (1) WO2001042307A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002057283A1 (en) * 2001-01-19 2002-07-25 Baylor College Of Medecine Methods and compositions in breast cancer diagnosis and therapeutics
WO2004005497A1 (ja) * 2002-07-02 2004-01-15 Yamanouchi Pharmaceutical Co., Ltd. インスリン抵抗性改善薬スクリーニング方法
EP2977470B1 (en) 2002-10-16 2018-01-03 Gen-Probe Incorporated Compositions and methods for detecting west nile virus
US7927840B2 (en) 2006-09-11 2011-04-19 Gen Probe Incorporated Method for detecting West Nile Virus nucleic acids in the 3′ non-coding region
AU2003280793A1 (en) * 2002-11-15 2004-06-15 Sumitomo Chemical Company, Limited MUTANT ESTROGEN RECEPTOR-Alpha AND GENE THEREOF
EP1680447A2 (en) * 2003-10-24 2006-07-19 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Orthogonal gene switches
FR2863275B1 (fr) * 2003-12-09 2007-08-10 Biomerieux Sa Procede pour le diagnostic/pronostic du cancer du sein
EP1711606A2 (en) 2004-01-20 2006-10-18 Isis Pharmaceuticals, Inc. Modulation of glucocorticoid receptor expression
JP2006153656A (ja) * 2004-11-29 2006-06-15 Olympus Corp 反応カプセル、反応カプセルを使用した検査方法およびシステム
KR20140084232A (ko) 2011-10-25 2014-07-04 아이시스 파마수티컬즈 인코포레이티드 Gccr 발현의 안티센스 조절
MX2015016171A (es) 2013-06-19 2016-08-08 Seragon Pharmaceuticals Inc Moduladores del receptor de estrogeno de azetidina y usos de los mismos.
EA031077B1 (ru) 2013-06-19 2018-11-30 Серагон Фармасьютикалз, Инк. Модулятор рецептора эстрогена и его применения
BR112016020953A2 (pt) * 2014-03-13 2018-01-23 Hoffmann La Roche composto, kit, composição farmacêutica, uso de composto, método de tratamento e invenção
CN107531722B (zh) 2015-05-26 2020-07-17 豪夫迈·罗氏有限公司 杂环雌激素受体调节剂及其用途
US10179676B1 (en) 2017-07-26 2019-01-15 William Hagan Taylor Dispenser with self-closing cap

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987005049A1 (en) * 1986-02-20 1987-08-27 California Biotechnology Inc. Eucaryotic expression of steroid receptor proteins
FR2634495B1 (fr) * 1988-07-01 1990-10-26 Chambon Pierre Procede de preparation d'une proteine par des levures utilisant un systeme inductible, vecteurs et souches transformees correspondantes
AU8951191A (en) * 1990-10-29 1992-05-26 Dekalb Plant Genetics Isolation of biological materials using magnetic particles

Also Published As

Publication number Publication date
DE60035522D1 (de) 2007-08-23
JP4742483B2 (ja) 2011-08-10
CA2393045A1 (en) 2001-06-14
AU782142B2 (en) 2005-07-07
US20030207380A1 (en) 2003-11-06
AU1886801A (en) 2001-06-18
JP2003516137A (ja) 2003-05-13
EP1237925A1 (en) 2002-09-11
ATE366745T1 (de) 2007-08-15
US7582476B2 (en) 2009-09-01
WO2001042307A1 (en) 2001-06-14
EP1237925B1 (en) 2007-07-11

Similar Documents

Publication Publication Date Title
DE60035522T2 (de) Mutant er-alpha und nachweissysteme für transaktivierung
DE69032324T2 (de) Zusammensetzung und testverfahren eines elementes als antwort auf ein hormon
DE69709561T2 (de) Östrogen-Rezeptor
DE69231734T2 (de) Geerbte und somatische mutationen des apc-gens bei menschlichem colorectal-krebs
DE69132616T2 (de) Introns und exons des gens für cystische fibrose sowie mutationen an mehreren stellen des gens
DE69232537T2 (de) Rezeptoren der steroid/thyroid superfamilie von rezeptoren
DE3752284T2 (de) Hormon-rezeptor-verbindungen und methoden
DE68929043T2 (de) Für androgen-rezeptor-protein kodierende dna
DE69434166T2 (de) Menschliche metabotropische glutamatrezeptor untertype hmglur7 und verwandte dns-verbindungen
DE69631540T2 (de) Materialien und methoden mit bezug zur identifizierung und sequenzierung des krebs-suszeptilitaetsgens brca2 und dessen anwendungen
DE69433816T2 (de) Die bestimmung von nukleinsäuremutationen durch analyse des sputum
DE69333315T2 (de) Säugetier-rezeptoren für das melanocyten-stimulierendes hormon und deren verwendungen
DE69321580T2 (de) Car-rezeptoren und verwandte moleküle und entsprechende methoden
DE69233469T2 (de) Menschliche Calcium-Kanale und Verwendungen davon
DE60128830T2 (de) Regulierung der expression von eer-7, ein mitglied der lysyl oxidase genfamilie, durch oestrogenrezeptoren
DE69328549T2 (de) Für einen humanen serotoninrezeptor (5-ht4b) kodierende dns und ihre verwendung
DE69424209T2 (de) Tumorsuppressor-Gen Merlin und dessen Verwendungen
DE69108568T3 (de) Diagnose für bösartige hyperthermia im schwein.
DE69126931T2 (de) Polypeptide mit dopaminerger rezeptor-aktivität, für sie kodierende nukleinsäuren und ihre verwendung
DE69231689T2 (de) Zusammensetzung von antwortelementen und ihre verwendung als proben
EP0805204B1 (de) Nebenhoden-spezifisches Rezeptorprotein und dessen Verwendung
DE69734143T2 (de) Neue methoden zur charakterisierung von verbindungen, welche die stf-1 expression in inselzellen der bauchspeicheldrüse stimuliert
DE69131289T2 (de) Polypeptide mit einer aktivität des menschlichen dopaminergischen rezeptors, deren kodierende nukleinsäuresequenzen und verwendung dieser polypeptide
DE69734725T2 (de) Neues verfahren zur überprüfung des differenzierungszustands pankreatischer zellen eines säugetiers
DE60030796T2 (de) Zelle zur Bestimmung der Fähigkeit die Aktivität eines Liganden-abhängigen Transkriptionskontrollfaktors zu kontrollieren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition